Page last updated: 2024-10-30

metformin and Injuries, Eye

metformin has been researched along with Injuries, Eye in 1 studies

Metformin: A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289)
metformin : A member of the class of guanidines that is biguanide the carrying two methyl substituents at position 1.

Research Excerpts

ExcerptRelevanceReference
" In vivo, metformin treatment significantly increased the number of surviving RGCs, the b/NR wave amplitude and the thickness of the inner retina but had no obvious adverse effects on the fundus."1.72Regulation of mitophagy by metformin improves the structure and function of retinal ganglion cells following excitotoxicity-induced retinal injury. ( Hu, FY; Liu, HL; Wu, JH; Xu, P, 2022)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Liu, HL1
Hu, FY1
Xu, P1
Wu, JH1

Other Studies

1 other study available for metformin and Injuries, Eye

ArticleYear
Regulation of mitophagy by metformin improves the structure and function of retinal ganglion cells following excitotoxicity-induced retinal injury.
    Experimental eye research, 2022, Volume: 217

    Topics: Animals; Apoptosis; Eye Injuries; Lactate Dehydrogenases; Metformin; Mitophagy; N-Methylaspartate; R

2022